Illinois Municipal Retirement Fund Sells 2,333 Shares of Intuitive Surgical, Inc. $ISRG

Illinois Municipal Retirement Fund lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,600 shares of the medical equipment provider’s stock after selling 2,333 shares during the period. Illinois Municipal Retirement Fund’s holdings in Intuitive Surgical were worth $4,293,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Brighton Jones LLC raised its position in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the last quarter. Sivia Capital Partners LLC grew its stake in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the period. Harbour Investments Inc. boosted its position in shares of Intuitive Surgical by 95.5% in the second quarter. Harbour Investments Inc. now owns 2,976 shares of the medical equipment provider’s stock worth $1,617,000 after purchasing an additional 1,454 shares during the period. Mutual Advisors LLC increased its stake in Intuitive Surgical by 5.7% in the 2nd quarter. Mutual Advisors LLC now owns 1,605 shares of the medical equipment provider’s stock worth $796,000 after buying an additional 86 shares in the last quarter. Finally, Nordea Investment Management AB grew its position in shares of Intuitive Surgical by 6.2% during the second quarter. Nordea Investment Management AB now owns 43,921 shares of the medical equipment provider’s stock worth $23,632,000 after purchasing an additional 2,549 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. Argus dropped their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, January 21st. BTIG Research reaffirmed a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $617.23.

Insider Transactions at Intuitive Surgical

In other news, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares in the company, valued at $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. This represents a 50.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 56,189 shares of company stock valued at $30,785,441 over the last three months. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $485.84 on Friday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $609.08. The stock has a market capitalization of $172.54 billion, a price-to-earnings ratio of 61.58, a PEG ratio of 3.76 and a beta of 1.65. The business has a fifty day moving average price of $541.62 and a 200-day moving average price of $510.34.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the company posted $2.21 earnings per share. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.